ANXA1 (Ac2-26) is a well-established anti-inflammatory compound that has shown therapeutic potential in a variety of disease models, including lung injury, acute colitis, kidney transplantation and diabetic nephropathy [41]. The gene discussed is ANXA1; the disease is diabetic kidney disease.